Founded in 2015, Telluris Biotech operates in Agritech industry. The company initially focused on developing biological seed treatment products aimed at combating crop diseases and has since expanded ...
Funding stage:
Series A
Last funding:
25/03/2024
Total funding:
$4.75 Mn+
Revenue:
Investors
Employee count:
29
Last 90d
29
Last 90d
Web traffic:
155
155
Last 30d
Last 30d
Glassdoor Rating:
Telluris Biotech: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders16
Latest Filing Date07 May 2026- Funding Events20
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Telluris Biotech
As of 08 May 2026, Telluris Biotech's equity is held by 15 shareholders, with the top three being Venu Polineni, Innovation In Food And Agriculture Fund, and Misimi Alapati.
Venu Polineni holds the largest stake in Telluris Biotech at 54.6% as of 08 May 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links